BILLERICA, Mass., Oct. 6 — Seahorse Bioscience todayannounced the release of the first ever analytical instrument for the kineticmeasurement of mitochondrial oxygen consumption and cytoplasmic glycolysis incells in a 96 well microplate. For the past 75 years tools for measuringcellular bioenergetics have been relatively unchanged since Warburg designedthe Warburg Apparatus in 1932 and Leland Clark […]
LIBERTYVILLE, Ill. & CARLSBAD, Calif. & WOODRIDGE, Ill.–Families of Spinal Muscular Atrophy (FSMA, www.curesma.org), Invitrogen Corporation (NASDAQ:IVGN)(www.invitrogen.com), and deCODE chemistry & biostructures (www.decodechembio.com) announced today they have identified a protein that is a potential molecular target for the treatment of Spinal Muscular Atrophy (SMA). In its most severe form, SMA often leads to death in […]
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today congratulates the three winners of the 2008 Nobel Prize in chemistry: Drs. Roger Tsien, Osamu Shimomura and Martin Chalfie, all of whom contributed to developing and expanding the use of fluorescent proteins in biological applications. Fluorescent proteins, including those […]
Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos’ new Muse(TM) de novo design product, which is targeted for commercial release in the fourth quarter […]
SOUTH EASTON, Mass., Oct. 8 — Pressure BioSciences, Inc. (Nasdaq: PBIO) (“PBI”) today provided an update on various corporate activities, including the presentation of favorable data generated by scientists at Amgen, Inc. on the Company’s pressure cycling technology (“PCT”), the scheduled presentation by Dr. Paul Pevsner of the NYU School of Medicine on the use […]
BEVERLY, Mass.–Hamilton Thorne, Inc. announced today that it has finalized a OEM partnership agreement with KD Secure, Inc., Cambridge, MA. The agreement gives Hamilton Thorne exclusive rights to manufacture, market and distribute the intelligent monitoring technology developed by KD Secure within the fields of regenerative medicine and transgenic research. “We look forward to working with […]
Affymetrix Inc., (Nasdaq:AFFX) today announced that one of South Africa’s largest public core labs has begun offering genomic research on the Affymetrix GeneChip(R) platform. The Centre for Proteomic and Genomic Research (CPGR) is using many Affymetrix GeneChip arrays, such as the exon array and the SNP Array 6.0, to explore applications with molecular diagnostics potential, […]
New Thermo Scientific Nunc EasyFill Cell Factory is a Space-saving “Out-of-the-Box” Solution Offering High-yield Efficiency and Process Flexibility ROSKILDE, DENMARK and ROCHESTER, N.Y. (October 7, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the new Thermo Scientific Nunc EasyFill Cell Factory, an easy-to-use multi-layer system for production-scale cell culture. […]
BEVERLY, Mass.–Hamilton Thorne, Inc. announced today that it has finalized a OEM partnership agreement with KD Secure, Inc., Cambridge, MA. The agreement gives Hamilton Thorne exclusive rights to manufacture, market and distribute the intelligent monitoring technology developed by KD Secure within the fields of regenerative medicine and transgenic research. “We look forward to working with […]
MADISON, Wis–Researchers from France investigating DNA copy number changes associated with genetic disorders have reported the development and validation of a Roche NimbleGen CGH multiplex, microarray-based research method for detecting genomic deletions and duplications at high-resolution. The findings, published in the August 5 issue of the journal Human Mutation (1), identified highly precise, exon-level variants […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
